UK's Cell Therapy Catapult awarded planning permission for immunotherapy plant
The UK’s Cell Therapy Catapult has received planning permission to build a £55m ($87m) large-scale manufacturing plant.
Archives for August 24, 2015
Roche buys Kapa to boost sequencing technology offering
Roche has added technology to tailor enzymes for specific applications in next-generation DNA and RNA sequencing through the acquisition of Kapa Biosystems.